Correlation Between 929043AK3 and Lipocine

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both 929043AK3 and Lipocine at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 929043AK3 and Lipocine into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between VNO 215 01 JUN 26 and Lipocine, you can compare the effects of market volatilities on 929043AK3 and Lipocine and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 929043AK3 with a short position of Lipocine. Check out your portfolio center. Please also check ongoing floating volatility patterns of 929043AK3 and Lipocine.

Diversification Opportunities for 929043AK3 and Lipocine

0.02
  Correlation Coefficient

Significant diversification

The 3 months correlation between 929043AK3 and Lipocine is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding VNO 215 01 JUN 26 and Lipocine in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Lipocine and 929043AK3 is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on VNO 215 01 JUN 26 are associated (or correlated) with Lipocine. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Lipocine has no effect on the direction of 929043AK3 i.e., 929043AK3 and Lipocine go up and down completely randomly.

Pair Corralation between 929043AK3 and Lipocine

Assuming the 90 days trading horizon VNO 215 01 JUN 26 is expected to generate 0.5 times more return on investment than Lipocine. However, VNO 215 01 JUN 26 is 2.02 times less risky than Lipocine. It trades about -0.24 of its potential returns per unit of risk. Lipocine is currently generating about -0.35 per unit of risk. If you would invest  9,570  in VNO 215 01 JUN 26 on November 29, 2024 and sell it today you would lose (1,072) from holding VNO 215 01 JUN 26 or give up 11.2% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy95.45%
ValuesDaily Returns

VNO 215 01 JUN 26  vs.  Lipocine

 Performance 
       Timeline  
VNO 215 01 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days VNO 215 01 JUN 26 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest inconsistent performance, the Bond's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for VNO 215 01 JUN 26 investors.
Lipocine 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Lipocine has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

929043AK3 and Lipocine Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with 929043AK3 and Lipocine

The main advantage of trading using opposite 929043AK3 and Lipocine positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 929043AK3 position performs unexpectedly, Lipocine can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Lipocine will offset losses from the drop in Lipocine's long position.
The idea behind VNO 215 01 JUN 26 and Lipocine pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Complementary Tools

Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Money Managers
Screen money managers from public funds and ETFs managed around the world
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Equity Valuation
Check real value of public entities based on technical and fundamental data
Stocks Directory
Find actively traded stocks across global markets